Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Saved in:
| Title: | Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. |
|---|---|
| Authors: | Nakamura N; Department of Hematology, Shinko Hospital, 1-4-47, Wakihamacho, Chuo-Ku, Kobe, Hyogo, 651-0072, Japan. n_nakamura@kuhp.kyoto-u.ac.jp.; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, Kyoto, Japan. n_nakamura@kuhp.kyoto-u.ac.jp., Arima N; Department of Hematology, Shinko Hospital, 1-4-47, Wakihamacho, Chuo-Ku, Kobe, Hyogo, 651-0072, Japan., Takakuwa T; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Yoshioka S; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan., Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan., Fukushima K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan., Hotta M; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan., Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Kanda J; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, Kyoto, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Tanaka H; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan., Ohta K; Hematology Ohta Clinic, Shinsaibashi, Japan., Kosugi S; Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Toyonaka, Japan., Yagi H; Department of Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan., Yoshihara S; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan., Yamamura R; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Nakatsu, Japan., Adachi Y; Department of Internal Medicine, JCHO Kobe Central Hospital, Kobe, Japan., Hanamoto H; Department of Hematology, Kindai University Nara Hospital, Nara, Japan., Shibayama H; Department of Hematology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Hosen N; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan., Ito T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan., Shimazaki C; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Takaori-Kondo A; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan., Hino M; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. |
| Corporate Authors: | Kansai Myeloma Forum |
| Source: | Annals of hematology [Ann Hematol] 2024 Dec; Vol. 103 (12), pp. 5681-5690. Date of Electronic Publication: 2024 Mar 16. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-024-05705-z |
